Skip to main content

Table 2 The seropositive results of TORCH agents

From: TORCH screening used appropriately in China?─three years results from a teaching hospital in northwest China

 

TOX: n (%)

RV: n (%)

CMV: n (%)

HSV-1: n (%)

HSV-2: n (%)

Ig G

IgM

Both

Ig G

IgM

Both

Ig G

IgM

Both

Ig G

IgM

Both

Ig G

IgM

Both

Overall

594 (4.35)

64 (0.35)

6 (0.04)

12,299 (90.00)

114 (0.63)

75 (0.55)

13,227 (96.79)

176 (0.97)

138 (1.01)

11,084 (81.11)

26 (0.14)

26 (0.19)

834 (6.10)

153 (0.85)

39 (0.29)

Year

 2015

237 (4.8)

7 (0.14)

3 (0.06)

4561 (92.38)

24 (0.48)

22 (0.45)

4784 (96.9)

16 (0.32)

16 (0.32)

4068 (82.4)

12 (0.24)

12 (0.24)

295 (5.98)

39 (0.79)

11 (0.22)

 2016

180 (4.47)

9 (0.14)

0 (0)

3652 (90.62)

23 (0.36)

16 (0.39)

3898 (96.72)

18 (0.28)

18 (0.45)

3311 (82.16)

14 (0.22)

12 (0.19)

237 (5.88)

35 (0.55)

8 (0.2)

 2017

177 (3.77)

48 (0.71)

3 (0.06)

4086 (86.95)

67 (0.99)

37 (0.79)

4545 (96.72)

142 (2.1)

104 (2.21)

3705 (78.85)

2 (0.03)

2 (0.04)

302 (6.43)

79 (1.69)

20 (0.43)

p-value

0.041

0.000

0.284

0.000

0.000

0.023

0.852

0.000

0.000

0.000

0.005

0.006

0.510

0.000

0.108

Maternal age

 20~25 years

89 (4.27)

13 (0.49)

2 (0.1)

1870 (89.82)

21 (0.79)

16 (0.77)

2007 (96.4)

20 (0.75)

16 (0.77)

1676 (80.5)

5 (0.19)

3 (0.14)

130 (6.24)

30 (1.13)

11 (0.53)

 26~29 years

301 (4.05)

33 (0.34)

2 (0.03)

6706 (90.16)

56 (0.57)

40 (0.54)

7195 (96.73)

98 (1.0)

75 (1.01)

6038 (81.18)

13 (0.13)

13 (0.17)

446 (6.00)

72 (0.74)

16 (0.22)

 ≥ 30 years

204 (4.92)

18 (0.32)

2 (0.05)

3723 (89.80)

37 (0.65)

19 (0.46)

4025 (97.08)

58 (1.02)

47 (1.13)

3370 (81.28)

10 (0.18)

10 (0.24)

258 (6.22)

51 (0.9)

12 (0.29)

p-value

0.086

0.434

0.407

0.789

0.447

0.289

0.326

0.455

0.397

0.737

0.696

0.64

0.850

0.132

0.06

Period

 Before pregnancy

295 (4.49)

30 (0.32)

3 (0.03)

5910 (89.94)

68 (0.73)

40 (0.61)

6343 (96.53)

78 (0.83)

52 (0.79)

5297 (80.61)

17 (0.18)

6 (0.09)

416 (6.33)

86 (0.92)

16 (0.24)

 First trimester

132 (4.0)

14 (0.38)

1 (0.03)

2970 (90.08)

21 (0.57)

20 (0.61)

3194 (96.88)

39 (1.05)

35 (1.06)

2672 (81.04)

5 (0.14)

5 (0.15)

174 (5.28)

25 (0.68)

11 (0.33)

 Second trimester

153 (4.38)

17 (0.39)

1 (0.03)

3143 (90.06)

18 (0.41)

14 (0.4)

3391 (97.16)

52 (1.19)

45 (1.29)

2875 (82.38)

5 (0.11)

4 (0.11)

219 (6.28)

39 (0.89)

10 (0.29)

 Third trimester

14 (4.56)

3 (0.43)

1 (0.32)

276 (89.90)

7 (1.01)

1 (0.33)

299 (97.39)

7 (1.01)

6 (1.95)

240 (78.18)

1 (0.14)

1 (0.33)

25 (8.14)

3 (0.43)

2 (0.65)

p-value

0.729

0.888

0.117

0.996

0.096

0.511

0.329

0.228

0.034

0.091

0.803

0.603

0.074

0.331

0.548

Group

 BOH

47 (4.22)

9 (0.33)

1 (0.09)

1004 (90.04)

30 (1.1)

6 (0.54)

1082 (97.04)

40 (1.46)

19 (1.70)

987 (88.52)

16 (1.43)

15 (1.35)

69 (6.19)

35 (1.28)

9 (0.81)

 Normal control

549 (4.36)

55 (0.36)

5 (0.04)

11,295 (89.65)

84 (0.55)

69 (0.55)

11,592 (92.01)

136 (0.89)

121 (0.96)

10,097 (80.14)

12 (0.10)

11 (0.09)

765 (6.07)

118 (0.77)

30 (0.24)

p-value

0.871

0.492

0.399

0.716

0.002

1.000

0.000

0.006

0.028

0.000

0.000

0.000

0.851

0.010

0.003